Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Business Today
UK orders 5 million doses of Moderna's COVID-19 vaccine, expects spring arrival

Interim data from a late-stage trial indicated Moderna's vaccine was 94.5% effective in preventing COVID-19


Moderna had announced on November 16 that after Phase 3 of trials their COVID-19 vaccine candidate was 94.5% effective in preventing coronavirus infection

Matt Hancock said the government was working hard to be able to roll-out the vaccine when it becomes available

Based on the Phase 2/3 trial results, SII with the help of ICMR will pursue the early availability of this product for India